Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 ICON Opens Translational Unit in Manchester | Contract Pharma
Breaking News

ICON Opens Translational Unit in Manchester

ICON has opened a purpose-built clinical pharmacology unit in the Central Manchester University Hospitals Foundation Trust (CMFT) campus in Manchester, UK.

ICON has opened a purpose-built clinical pharmacology unit in the Central Manchester University Hospitals Foundation Trust (CMFT) campus in Manchester, UK. In June the company began initial studies at the unit using translational medicine methodologies to expedite drug development projects.

The 34-bed hospital-based unit brings ICON’s Phase I global bed capacity to more than 280 beds, and includes a sample handling lab, 24-hour medical cover, local GMP pharmacy, access to the Accident and Emergency department at the Manchester Royal Infirmary and local bioanalytical support. The unit also features four pharmacodynamic testing suites, where ICON models pathologies to identify early efficacy signals of compounds in clinical areas such as Neuropathic Pain, Anxiety and Cognitive Degeneration.

Alan Morgan, ICON group president, Early Clinical Research, commented, “ICON has conducted clinical pharmacology studies in Manchester for over 25 years, and the opening of this translational medicine unit further demonstrates our commitment to streamlining the process that guides new compounds through the early phases of development into treatments that improve human health. Our collaborative relationship with the CMFT, and the location of the new unit on one of the largest teaching hospitals in the UK, facilitates unrivalled access to the expertise, specialist procedures and patient populations necessary to bring life saving medicines to market faster.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters